What MedCheck does

MedCheck (legal entity MEDCHECK E-COMMERCE, INC.) is a privately held health-technology company founded in 2016 and headquartered in Makati City, Philippines, with a regional office in Singapore and an Indonesia presence via distributor Arianda Group. The company operates a cloud-based Real-World Data (RWD) platform for emerging markets, anchored on three core products: a Clinical Studies Portal (21 CFR Part 11 compliant), a specialty-customized Electronic Medical Records (EMR) system with built-in data analytics, and a Data Analytics & Registry engine. The platform is extended through Digital Disease Registries, a Patient Support Digital Platform, a Patient Portal with online booking and digital remote triage, an Integrated Special Access Program (iSAP), and FHIR/HL7-compatible API integration with existing hospital information systems (HIS), laboratory information systems (LIS), and radiology information systems (RIS).

MedCheck serves three primary B2B segments — life sciences (pharmaceutical, biotech, and medical device companies), medical societies and specialty institutes, and hospitals, clinics, and practitioners — alongside a free consumer-facing patient portal. The company lists nine multinational pharma, biotech, and device counterparties (MSD, Roche, Boehringer Ingelheim, Sanofi, Takeda, Sandoz, Medtronic, AstraZeneca, and Inova Diagnostics), the Philippine Department of Health, multiple specialty societies (Philippine College of Surgeons, HPBS, Diabetes Philippines, PCCP), and leading Philippine hospitals (PGH, Lung Center of the Philippines, Jose Reyes Medical Center, UST Hospital, The Medical City, St. Luke's Medical Center, and RITM) as partners.

The business model is enterprise SaaS with annual quote-based subscriptions for life sciences, medical society, and hospital customers, plus data monetization through licensing of its National and Regional Aggregated RWD Registry Database, managed services around patient support programs, and a free patient self-registration portal. Distribution is consultative enterprise sales gated by Request Demo CTAs, complemented by FHIR/HL7 API integration for technical buyers and a channel-partner (Arianda Group) motion in Indonesia. Security and compliance posture includes 21 CFR Part 11, HIPAA-aligned controls, 256-bit SSL/HTTPS encryption, and adherence to the Philippines Data Privacy Act (RA 10173), with a guaranteed 99% network uptime SLA. Disclosed funding is limited to a $30,000 Seedstars seed round in 2020 and an undisclosed 2022 round from Ideaspace Ventures and Manila Angel Investors Network, with no reported Series A or larger institutional round.

Name

MedCheck

Legal name

MEDCHECK E-COMMERCE, INC.

Website

https://medcheck.com.ph

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

MedCheck is a Philippines-headquartered health-technology company that operates a cloud-based Real-World Data platform serving life sciences companies, medical societies, and hospitals across the Philippines, Singapore, and Indonesia, anchored on a 21 CFR Part 11 compliant Clinical Studies Portal and specialty EMR.

Ownership category

akta.pro rank

Product category

Healthcare Real-World Data Platform

NAICS

Computer Systems Design and Related Services (54151), Medical and Diagnostic Laboratories (62151)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)

akta.pro secondary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Real-world data platforms
• Clinical study software
• Electronic medical records
• Digital disease registries
• Healthcare interoperability

Headquarters

HQ city

Makati

HQ country

Philippines

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Life Sciences / Clinical Research SaaS subscriptions: Recurring B2B software subscriptions sold to pharmaceutical, biotech, and medical device companies for access to Real-World Data (RWD) databases, clinical study feasibility and recruitment, RWD management for clinical research and publications, and biostatistical analysis. Sales are consultative ('Request Demo' gate).
2. Medical Society & Specialty Institute SaaS subscriptions: Subscription software deployed for medical societies and specialty institutes covering digital disease registries, registry integration (API), specialty-customized EMR/EHR, patient support platforms, clinical study feasibility, and biostatistical analysis.
3. Hospital, Clinic & Practitioner Software Licenses: Per-organization deployment of EMR/EHR, clinic management software, OPD administration, concierge & triage portals, inventory and billing management, and registry/API integrations, sold into hospitals, clinics, and individual practitioners.
4. Aggregated Real-World Data Licensing: License/access fees derived from MedCheck's National and Regional Aggregated RWD Registry Database, supplied to partners, affiliates, and clients for research purposes in non-identifiable form.
5. Patient Support / Special Access Program Services: Programmatic revenue tied to enabling pharmaceutical-sponsored patient support programs and the Integrated Special Access Program (iSAP), including clinical study participation recruitment and patient-candidate submission services.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

MedCheck operates a cloud-based Real-World Clinical Data platform for emerging markets, anchored by a Clinical Studies Portal (21 CFR Part 11 compliant), an Electronic Medical Records (EMR) system with specialty-customized forms for cardiology, endocrinology, and oncology, and a Data Analytics & Registry engine. The platform supports digital disease registries, FHIR/HL7 interoperability with hospital information systems, and services such as clinical study feasibility, recruitment, real-world data management, and biostatistical analysis for life sciences, medical societies, hospitals, and clinics.

Product overview

MedCheck offers a unified cloud-based Real-World Data platform for emerging-market healthcare, built around three core products — the Clinical Studies Portal, the Electronic Medical Records (EMR) platform, and Data Analytics & Registry — that share data through a 21 CFR 11 compliant, FHIR/HL7-interoperable infrastructure. The core platform is extended by a set of complementary modules including Digital Disease Registries, the Patient Support Digital Platform, the Patient Portal (with online booking and digital remote triage), the Concierge and Triage Management Portal, Outpatient Department Administration, and Inventory and Billing Management, all of which feed into MedCheck's National and Regional Registry Database. On top of this platform MedCheck delivers Life Sciences services such as Clinical Study Feasibility, Clinical Study Recruitment, Real-World Clinical Data Management, and Biostatistical Analysis, plus a Find a Doctor directory and an Integrated Special Access Program (iSAP) for patients.

Differentiator

Problem solved

Functional benefit

Brands

• iSAP (Integrated Special Access Program): Integrated Special Access Program referenced as a MedCheck service/quick link on the company website.

Products and services

• Clinical Studies Portal 21 CFR Part 11 compliant portal offering digital disease registries, electronic case study forms (eCRFs), and electronic medical records to support clinical studies for medical societies and life sciences organizations.
• Electronic Medical Records (EMR) Cloud-based EMR platform custom-designed for specialists, with specialty forms for cardiology, endocrinology, and oncology, providing 24/7 access, built-in data analytics, 256-bit SSL/HTTPS encryption, and a 24/7 concierge support team.
• Data Analytics & Registry Data analytics and tailored data registry service that aggregates clinical and treatment data from across MedCheck's healthcare network to deliver actionable insights and study health trends in patient populations.
• Digital Disease Registries Digital registries for collecting, aggregating, and analyzing clinical disease and treatment data for specialty organizations' own research, supported by a National and Regional Registry Database aggregating de-identified data for research purposes.
• Integrated Special Access Program (iSAP) Patient-facing offering accessible via the iSAP landing page for integrated special access programs supporting sponsored treatment access and clinical study participation.
• Clinical Study Feasibility Service using MedCheck's real-world data database across hundreds of thousands of patients to evaluate optimal locations and patient pools for clinical studies and research.
• Clinical Study Recruitment Service for efficiently identifying and connecting eligible patients for clinical studies using MedCheck's physician network and integrated patient candidate submission.
• Real-World Clinical Data Management for Clinical Research & Publications Service using MedCheck's 21 CFR Part 11 compliant software to digitally structure, validate, and aggregate real-world data (RWD) for clinical research and publications.
• Biostatistical Analysis Statistical analysis service that produces insights for clinical research and studies using MedCheck's aggregated real-world data.
• Real-World Database for Specific Diseases Access to MedCheck's large real-world data database for specific disease and treatment data in emerging markets, supplied to life sciences customers for research purposes in non-identifiable form.
• Find a Doctor Patient-facing directory tool that helps patients find and schedule appointments with physicians across MedCheck's network.

Quantifiable outcome

• Real-World Database spanning hundreds of thousands of patients in emerging markets accessible for clinical study feasibility
• +3 more outcomes

Named customers17 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

Feature8 records

Partnerships

15 partnerships are on record, tiered major and core.

• MSD (Merck Sharp & Dohme)majorStrategic or Co-development PartnerMSD is listed on MedCheck's Partners page under 'Medical Pharma, Biotech, Devices,' indicating a commercial/strategic relationship around Real-World Data, clinical study feasibility, and clinical study recruitment in emerging markets.
• Hoffmann-La RochemajorStrategic or Co-development PartnerRoche is listed on MedCheck's Partners page under 'Medical Pharma, Biotech, Devices,' indicating a commercial/strategic relationship around Real-World Data, clinical study feasibility, and clinical study recruitment in emerging markets.
• Boehringer IngelheimmajorStrategic or Co-development PartnerBoehringer Ingelheim is listed on MedCheck's Partners page under 'Medical Pharma, Biotech, Devices,' indicating a commercial/strategic relationship around Real-World Data, clinical study feasibility, and clinical study recruitment in emerging markets.
• SanofimajorStrategic or Co-development PartnerSanofi is listed on MedCheck's Partners page under 'Medical Pharma, Biotech, Devices,' indicating a commercial/strategic relationship around Real-World Data, clinical study feasibility, and clinical study recruitment in emerging markets.
• TakedamajorStrategic or Co-development PartnerTakeda is listed on MedCheck's Partners page under 'Medical Pharma, Biotech, Devices,' indicating a commercial/strategic relationship around Real-World Data, clinical study feasibility, and clinical study recruitment in emerging markets.
• SandozmajorStrategic or Co-development PartnerSandoz is listed on MedCheck's Partners page under 'Medical Pharma, Biotech, Devices,' indicating a commercial/strategic relationship around Real-World Data, clinical study feasibility, and clinical study recruitment in emerging markets.
• MedtronicmajorStrategic or Co-development PartnerMedtronic is listed on MedCheck's Partners page under 'Medical Pharma, Biotech, Devices,' indicating a commercial/strategic relationship around Real-World Data, clinical study feasibility, and clinical study recruitment in emerging markets.
• AstraZenecamajorStrategic or Co-development PartnerAstraZeneca is listed on MedCheck's Partners page under 'Medical Pharma, Biotech, Devices,' indicating a commercial/strategic relationship around Real-World Data, clinical study feasibility, and clinical study recruitment in emerging markets.
• Inova DiagnosticsmajorStrategic or Co-development PartnerInova Diagnostics is listed on MedCheck's Partners page under 'Medical Pharma, Biotech, Devices,' indicating a commercial/strategic relationship around Real-World Data, clinical study feasibility, and clinical study recruitment in emerging markets.
• Philippine College of Surgeons (PCS)majorStrategic or Co-development PartnerListed under 'Medical Societies' on MedCheck's Partners page; partner relationship on specialty registries and clinical research enablement in the Philippines.
• Philippine Department of Health (DOH)majorStrategic or Co-development PartnerListed under 'Medical Societies' on MedCheck's Partners page; partnership around digital disease registries, data sharing, and national/regional registry initiatives.
• Hepatopancreatobiliary Society (HPBS)coreStrategic or Co-development PartnerListed under 'Medical Societies' on MedCheck's Partners page; specialty society partnership (relevant to Chief Medical Advisor Dr. Catherine Teh, Regional KOL for Cancer of Liver, Pancreas, HPB).
• Diabetes PhilippinescoreStrategic or Co-development PartnerListed under 'Medical Societies' on MedCheck's Partners page; partnership around diabetes registry and clinical research.
• Philippine College of Chest Physicians (PCCP)coreStrategic or Co-development PartnerListed under 'Medical Societies' on MedCheck's Partners page; chest/pulmonology society partnership.
• Arianda GroupmajorChannel Partner/ Reseller/ DistributorIndonesia distributor for MedCheck, based at Arianda Building, Jl. Tentara Pelajar No. 25, Kebayoran Lama, Jakarta Selatan 12210. Enables MedCheck's Indonesia presence without a wholly-owned local entity.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• IQVIA: Global leader in clinical research services and real-world evidence for pharma/biotech. Competes with MedCheck for the same pharma RWD and feasibility budgets, but at much larger scale and with established global delivery.
• Veradigm (Allscripts): Enterprise EHR and practice management vendor with life sciences data assets (via its Veradigm/Practice Fusion division). Comparable to MedCheck on ambulatory EMR plus life-sciences RWD monetization, though with a much larger US-anchored footprint.
• Oracle Health (formerly Cerner): Enterprise EMR/EHR and population health incumbent used by large hospital systems globally. Competes with MedCheck's hospital EMR and integrated registries, but at vastly larger scale and with much broader functionality.
• Koninklijke Philips: Health technology conglomerate with deep presence in Southeast Asia across imaging, population health, and clinical informatics. Competes indirectly with MedCheck through hospital IT and clinical data platforms, especially in Indonesia and Singapore.
• Epic Systems: Dominant US hospital EMR with growing international footprint. Competes with MedCheck's EMR/EHR business and is increasingly integrating research and registry modules that overlap with MedCheck's specialty registry proposition.

Direct peers

• TriNetX: Global federated real-world data network used for clinical study feasibility, patient recruitment, and real-world evidence — same core use cases MedCheck sells into pharma, with broader global coverage but less emerging-market depth.
• Flatiron Health: US-based oncology-focused real-world data and clinical research platform serving life sciences customers — directly comparable to MedCheck's life-sciences RWD, registry, and clinical study enablement stack. Flatiron is also represented on MedCheck's advisory bench via former VP Growth Sahir Raoof.
• Tempus: AI-enabled precision medicine company that aggregates de-identified clinical and molecular data to sell insights to life sciences. Closely parallels MedCheck's RWD-for-specific-diseases offering, particularly in oncology, where Tempus is a primary global competitor.
• Aetion: Real-world evidence analytics platform for biopharma, regulators, and payers. Comparable in selling RWD-derived analytic outputs to pharma, although Aetion focuses on analytics software rather than primary data capture through an EMR.

Emerging players

• Iterative Health: Specialty-focused (gastroenterology) clinical research and AI company whose founder sits on MedCheck's advisory board. Comparable as a smaller, specialty-verticalized health-data and clinical-research platform, although operating in a different therapeutic area and geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/medcheckph
• LinkedInlinkedin.com/company/medcheckph

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MedCheck